Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection

被引:14
作者
Chae, Hyun-Dong [1 ]
Kim, In-Hwan [1 ]
机构
[1] Catholic Univ Daegu, Sch Med, Dept Surg, 3056-6,Daemyung 4 Dong, Daegu 705718, South Korea
关键词
CEA; gastric cancer; RT-PCR; peritoneal recurrence; peritoneal wash; POLYMERASE CHAIN-REACTION; FREE TUMOR-CELLS; QUANTITATIVE DETECTION; SEROSAL INVASION; LAVAGE CYTOLOGY; CARCINOMA; PREDICTOR; MICROMETASTASIS; STOMACH; CAVITY;
D O I
10.3109/00365521.2016.1172339
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Peritoneal recurrence is the most common cause of death after surgery for gastric cancer. Reverse transcriptase polymerase chain reaction (RT-PCR) analysis has been used to detect free cancer cells in peritoneal wash during surgery. This study was conducted to evaluate the prognostic significance of carcinoembrionic antigen (CEA) mRNA detected by RT-PCR in peritoneal wash from patients with gastric cancer after curative resection through a 5-year follow-up.Materials and methods: Peritoneal wash were obtained from 117 patients who underwent curative surgery for gastric cancer. The association between the CEA RT-PCR results, clinicopathological factors, and factors affecting gastric cancer recurrence were evaluated.Results: Among the 117 cases, 38 (32.5%) revealed positive CEA expression. Patients with positive CEA expression showed a higher rate of peritoneal recurrence than those with negative CEA expression (p=0.047). Depth of invasion, lymph node metastasis, TNM stage, and CEA expression were factors affecting recurrence. CEA expression and depth of invasion were significant prognostic factors in a multivariate analysis, and CEA expression was the most important prognostic factor for recurrence in patients who had undergone curative resection for gastric cancer (hazard ratio: 2.747, p=0.046).Conclusions: CEA expression in the peritoneal wash was significantly associated with peritoneal recurrence and was the most important prognostic factor for gastric cancer recurrence after curative resection.
引用
收藏
页码:956 / 960
页数:5
相关论文
共 25 条
[1]   Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma [J].
Bando, E ;
Yonemura, Y ;
Takeshita, Y ;
Taniguchi, K ;
Yasui, T ;
Yoshimitsu, Y ;
Fushida, S ;
Fujimura, T ;
Nishimuua, G ;
Miwa, K .
AMERICAN JOURNAL OF SURGERY, 1999, 178 (03) :256-262
[2]   The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection [J].
Bentrem, D ;
Wilton, A ;
Mazumdar, M ;
Brennan, M ;
Coit, D .
ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (05) :347-353
[3]   Peritoneal lavage cytology in gastric cancer: An independent predictor of outcome [J].
Burke, EC ;
Karpeh, MS ;
Conlon, KC ;
Brennan, MF .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (05) :411-415
[4]   Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives [J].
Fujiwara, Yoshiyuki ;
Doki, Yuichiro ;
Taniguchi, Hirokazu ;
Sohma, Itsuro ;
Takiguchi, Shuji ;
Miyata, Hiroshi ;
Yamasaki, Makoto ;
Monden, Morito .
GASTRIC CANCER, 2007, 10 (04) :197-204
[5]   THE 2ND BRITISH STOMACH-CANCER GROUP TRIAL OF ADJUVANT RADIOTHERAPY OR CHEMOTHERAPY IN RESECTABLE GASTRIC-CANCER - 5-YEAR FOLLOW-UP [J].
HALLISSEY, MT ;
DUNN, JA ;
WARD, LC ;
ALLUM, WH ;
ARNOTT, S ;
BAKER, P ;
BROOKES, VS ;
CRAVEN, JL ;
ELLIS, DJ ;
FIELDING, JWL ;
FAGG, SL ;
HOCKEY, MS ;
LEVISON, D ;
JONES, BG ;
KELLY, K ;
MASON, MC ;
MINAWA, A ;
MCADAM, A ;
TIMOTHY, A ;
WATERHOUSE, JAH ;
WINSEY, S ;
WRIGLEY, PFM .
LANCET, 1994, 343 (8909) :1309-1312
[6]  
IKEGUCHI M, 1994, ANTICANCER RES, V14, P2131
[7]  
Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681
[8]   Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011 [J].
Jung, Kyu-Won ;
Won, Young-Joo ;
Kong, Hyun-Joo ;
Oh, Chang-Mo ;
Lee, Duk Hyoung ;
Lee, Jin Soo .
CANCER RESEARCH AND TREATMENT, 2014, 46 (02) :109-123
[9]  
Kodera Y, 1999, J SURG ONCOL, V72, P60, DOI 10.1002/(SICI)1096-9098(199910)72:2<60::AID-JSO3>3.0.CO
[10]  
2-1